文献速递皮肤肿瘤

BRAF V600E突变黑素细胞在健康皮肤中形成亚临床场并富集于黑色素瘤与痣周围

Subclinical fields of BRAF V600E-mutant melanocytes populate human skin and are enriched around melanoma and naevi.
PubMed 文献 · Br J Dermatol · 2026-01-01

研究在97份澳大利亚高黑素瘤风险人群的临床和组织学健康非皮损皮肤样本中检测BRAF V600E突变。发现突变黑素细胞常见于痣和原发黑色素瘤周围皮肤,甚至肿瘤切除多年后仍存在,且肿瘤邻近皮肤中密度高达20倍、频率高50%。这些场细胞呈现BRAF V600E诱导的生长停滞基因表达特征,提示休眠但遗传预置状态。

要点

  • 健康皮肤中常见BRAF V600E突变黑素细胞,挑战突变必然致瘤的传统观点。
  • 突变细胞场在痣和黑色素瘤邻近皮肤中密度更高、更频繁。
  • 场细胞呈生长停滞转录特征,提示休眠但遗传预置,可能扩展黑色素瘤筛查范围。

核心结论

  • 正常皮肤中存在携带致癌基因的黑素细胞储库,BRAF V600E表达并非必然致瘤。
  • 亚临床BRAF V600E突变黑素细胞场常见于高黑素瘤风险成人皮肤,并富集于肿瘤邻近区域。

研究设计与样本

  • 研究检测97份来自澳大利亚高黑素瘤风险个体的组织学和临床健康非皮损皮肤样本中的BRAF V600E突变。
  • 样本包括痣或既往黑色素瘤部位邻近皮肤、黑色素瘤切除部位近端约5 cm的光损伤皮肤、远离病变的光保护皮肤及低风险新生儿包皮来源黑素母细胞。
  • 采用免疫组化定位BRAF V600E突变细胞,微滴数字PCR测定全皮肤BRAF V600E分数丰度,单细胞RNA测序确认细胞为黑素细胞并检测转录程序。

主要发现

  • 在痣和原发黑色素瘤周围皮肤中鉴定出BRAF V600E突变黑素细胞,甚至肿瘤切除多年后仍可检测到。
  • BRAF V600E突变黑素细胞场常见于高黑素瘤风险患者皮肤,肿瘤邻近皮肤中密度高达20倍、频率高50%。
  • 场细胞呈现BRAF V600E诱导的生长停滞特征性基因表达谱,与休眠但遗传预置细胞一致。

临床怎么用

  • 黑色素瘤检测和预防努力可考虑扩展至可见病变之外,涵盖驱动突变细胞的潜在癌前场。
  • 该发现可能推动新的皮肤筛查方法,在黑色素瘤发生前检测早期变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The origins of cutaneous melanoma are often traced to visible precursor lesions (e.g. melanocytic naevi), but approximately two-thirds of melanomas arise from clinically healthy skin with no detectable precursor lesion. The BRAF V600E mutation drives melanoma and naevus formation, but eruptive naevi syndromes and the disproportionate role early-life ultraviolet exposure plays in melanoma risk suggest the presence of a hidden field of oncogene-mutant melanocytes in clinically healthy skin, which may represent an earlier step in tumorigenesis. OBJECTIVES: To determine whether BRAF V600E-mutant melanocytes were commonly present in nonlesional skin from adults at high risk of melanoma. METHODS: We examined BRAF V600E mutations in 97 histologically and clinically healthy, nonlesional skin samples from an Australian cohort of individuals at high risk of melanoma. The skin selected was adjacent to a naevus or a prior melanoma site; photodamaged skin proximal (approximately 5 cm) from melanoma excision; photoprotected skin distant from lesions; and low-risk neonatal foreskin-derived melanoblasts. We used immunohistochemistry to locate BRAF V600E-mutant cells in histopathology sections; droplet digital polymerase chain reaction to determine the fractional abundance of BRAF V600E in whole skin; and single-cell RNA sequencing to confirm cells as melanocytes and detect their transcriptional programmes. RESULTS: We identified BRAF V600E-mutant melanocytes in skin surrounding naevi and primary melanomas, even years after tumour excision. Fields of BRAF V600E-mutant melanocytes were commonly found in the skin of patients at high risk for melanoma and were up to 20-fold denser and 50% more frequent in tumour-adjacent skin. Field cells exhibited a gene expression profile characteristic of BRAF V600E-induced growth arrest, consistent with dormant yet genetically primed cells. CONCLUSIONS: There is a reservoir of oncogene-harbouring melanocytes in normal skin. Our findings challenge the prevailing notion that melanocyte expression of BRAF V600E is inherently tumorigenic. The presence of such fields suggests that the scope of melanoma detection and prevention efforts might be extended beyond visible lesions, to encompass potentially precancerous fields of driver-mutant cells. An author video to accompany this article is available online. Melanoma is the deadliest form of skin cancer. The best chance of survival is through early detection and surgical removal. Most melanomas are caused by a change (or ‘mutation’) in a gene called ‘BRAF’. BRAF is active in a specific type of skin cells called ‘melanocytes’. The same mutation can also cause moles. Until now, it was thought that this mutation would almost always lead to either a mole or melanoma. In this study, researchers from Australia and the USA asked the question: Can BRAF mutations also be found in healthy-looking skin? To answer this, we examined 97 skin samples from people. Samples included skin from next to a mole or a melanoma scar, or from sun-exposed and sun-protected skin. Using highly sensitive analytical methods, we were able to detect even rare mutations and confirm which cells carried them. We found many examples of BRAF-mutant melanocytes in healthy-looking skin. These cells were denser and common in skin adjacent to moles or melanoma scars. The mutant cells appeared to be dormant (‘asleep’) but are probably ready to form a tumour under different circumstances. Without some outside influence, these cells do not become cancerous. Our findings suggest that there are BRAF mutant melanocytes in apparently healthy skin. This challenges the view that the BRAF mutation in melanocytes always leads to tumour formation. This discovery may lead to new methods of screening skin and detecting early melanoma in people before it develops.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Lee KJ, Kao YC, Jiang A, et al. Subclinical fields of BRAF V600E-mutant melanocytes populate human skin and are enriched around melanoma and naevi. Br J Dermatol. 2026. PMID: 41148046. doi:10.1093/bjd/ljaf412

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。